Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
60.29B
Market cap60.29B
Price-Earnings ratio
37.58
Price-Earnings ratio37.58
Dividend yield
0.74%
Dividend yield0.74%
Average volume
1.97M
Average volume1.97M
High today
$315.91
High today$315.91
Low today
$308.88
Low today$308.88
Open price
$315.70
Open price$315.70
Volume
1.16M
Volume1.16M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$267.40
52 Week low$267.40

Stock Snapshot

With a market cap of 60.29B, Cencora, Inc.(COR) trades at $309.93. The stock has a price-to-earnings ratio of 37.58 and currently yields dividends of 73.6%.

On 2026-03-31, Cencora, Inc.(COR) stock traded between a low of $308.88 and a high of $315.91. Shares are currently priced at $309.93, which is +0.3% above the low and -1.9% below the high.

The Cencora, Inc.(COR)'s current trading volume is 1.16M, compared to an average daily volume of 1.97M.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $267.40.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $267.40.

COR News

Simply Wall St 13h
Assessing Cencora Valuation After Recent Share Price Weakness And Premium P/E Ratio

Cencora (COR) has drawn attention after recent trading, with the share price at US$312.45 and negative returns over the past week, month and past 3 months, prom...

Assessing Cencora Valuation After Recent Share Price Weakness And Premium P/E Ratio
Simply Wall St 6d
Cencora Expands Retina Network With EyeSouth Deal And Earnings Focus

Cencora (NYSE:COR) has agreed to acquire the retina business of EyeSouth Partners. Affiliated physicians are expected to join Retina Consultants of America, wh...

Cencora Expands Retina Network With EyeSouth Deal And Earnings Focus
Seeking Alpha 7d
Cencora to buy EyeSouth Partners’ retina business for $1.1B

Medical distributor Cencora (COR) has signed an agreement to acquire EyeSouth Partners’ retina business for $1.1B through its eye care subsidiary, Retina Consul...

Cencora to buy EyeSouth Partners’ retina business for $1.1B

Analyst ratings

76%

of 17 ratings
Buy
76.5%
Hold
23.5%
Sell
0%

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.